Literature DB >> 12114240

Chronic renal disease.

Malvinder S Parmar1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12114240      PMCID: PMC1123635          DOI: 10.1136/bmj.325.7355.85

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


× No keyword cloud information.
  28 in total

1.  K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification.

Authors: 
Journal:  Am J Kidney Dis       Date:  2002-02       Impact factor: 8.860

2.  Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes.

Authors:  E J Lewis; L G Hunsicker; W R Clarke; T Berl; M A Pohl; J B Lewis; E Ritz; R C Atkins; R Rohde; I Raz
Journal:  N Engl J Med       Date:  2001-09-20       Impact factor: 91.245

Review 3.  The anemia of chronic renal failure: pathophysiology and the effects of recombinant erythropoietin.

Authors:  J W Eschbach
Journal:  Kidney Int       Date:  1989-01       Impact factor: 10.612

4.  Effect of lipid reduction on the progression of renal disease: a meta-analysis.

Authors:  L F Fried; T J Orchard; B L Kasiske
Journal:  Kidney Int       Date:  2001-01       Impact factor: 10.612

5.  The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes.

Authors:  H H Parving; H Lehnert; J Bröchner-Mortensen; R Gomis; S Andersen; P Arner
Journal:  N Engl J Med       Date:  2001-09-20       Impact factor: 91.245

6.  Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy.

Authors:  B M Brenner; M E Cooper; D de Zeeuw; W F Keane; W E Mitch; H H Parving; G Remuzzi; S M Snapinn; Z Zhang; S Shahinfar
Journal:  N Engl J Med       Date:  2001-09-20       Impact factor: 91.245

Review 7.  Smoking: a factor promoting onset and progression of diabetic nephropathy.

Authors:  E Ritz; H Ogata; S R Orth
Journal:  Diabetes Metab       Date:  2000-07       Impact factor: 6.041

8.  European best practice guidelines for the management of anaemia in patients with chronic renal failure. Working Party for European Best Practice Guidelines for the Management of Anaemia in Patients with Chronic Renal Failure.

Authors: 
Journal:  Nephrol Dial Transplant       Date:  1999       Impact factor: 5.992

Review 9.  Dietary protein intake and the progressive nature of kidney disease: the role of hemodynamically mediated glomerular injury in the pathogenesis of progressive glomerular sclerosis in aging, renal ablation, and intrinsic renal disease.

Authors:  B M Brenner; T W Meyer; T H Hostetter
Journal:  N Engl J Med       Date:  1982-09-09       Impact factor: 91.245

Review 10.  The long-term effects of recombinant human erythropoietin on the cardiovascular system.

Authors:  J W Eschbach; T Aquiling; N R Haley; M H Fan; C R Blagg
Journal:  Clin Nephrol       Date:  1992       Impact factor: 0.975

View more
  17 in total

1.  Recurrent hypoglycaemia in a diabetic patient as a result of unexpected renal failure.

Authors:  Malvinder S Parmar
Journal:  BMJ       Date:  2004-04-10

2.  The effect of TSH change per year on the risk of incident chronic kidney disease in euthyroid subjects.

Authors:  Da Young Lee; Jae Hwan Jee; Ji Eun Jun; Tae Hyuk Kim; Sang-Man Jin; Kyu Yeon Hur; Sun Wook Kim; Jae Hoon Chung; Moon-Kyu Lee; Jae Hyeon Kim
Journal:  Endocrine       Date:  2016-10-05       Impact factor: 3.633

Review 3.  Time to differentiate 'decreased kidney function' from 'kidney disease': towards improving the definition of chronic kidney disease.

Authors:  Malvinder S Parmar
Journal:  Int Urol Nephrol       Date:  2012-01-05       Impact factor: 2.370

4.  Excellent response to the clinical treatment of tophaceous gout.

Authors:  Cezar Augusto Muniz Caldas; Ricardo Fuller
Journal:  Clin Rheumatol       Date:  2006-10-18       Impact factor: 2.980

5.  Favorable coagulation profile with fondaparinux after hip surgery in elderly patients.

Authors:  Zuzana Kudrnová; Jan Kvasnička; Karel Kudrna; Jiří Mazoch; Ivana Malíková; Zuzana Zenáhlíková; Magda Sudrová; Radka Brzežková
Journal:  Int J Hematol       Date:  2009-10-17       Impact factor: 2.490

6.  Predicting the risk of chronic Kidney Disease in men and women in England and Wales: prospective derivation and external validation of the QKidney Scores.

Authors:  Julia Hippisley-Cox; Carol Coupland
Journal:  BMC Fam Pract       Date:  2010-06-21       Impact factor: 2.497

7.  Endothelin-1, big endothelin-1, and nitric oxide in patients with chronic renal disease and hypertension.

Authors:  Ivanka Mikulić; József Petrik; Kresimir Galesić; Zeljko Romić; Ivana Cepelak; Monika Zeljko-Tomić
Journal:  J Clin Lab Anal       Date:  2009       Impact factor: 2.352

8.  Renal Function and Hematology in Rats with Congenital Renal Hypoplasia.

Authors:  Hidenori Yasuda; Kohei Amakasu; Yuki Tochigi; Kentaro Katayama; Hiroetsu Suzuki
Journal:  Comp Med       Date:  2016-02       Impact factor: 0.982

9.  Renal impairment and coronary collaterals in patients with acute coronary syndrome.

Authors:  M Duran; O K Uysal; O Gunebakmaz; Y Yilmaz; M A Vatankulu; M Turfan; A O Duran; E Ornek; M Cetin; S N Murat; M G Kaya
Journal:  Herz       Date:  2013-05-08       Impact factor: 1.443

10.  Access to treatment for chronic kidney disease by children and adolescents in Brazil.

Authors:  Isabel de Pádua Paz; Tulio Konstantyner; Ricardo de Castro Cintra Sesso; Cristine Campos de Xavier Pinto; Maria Fernanda Carvalho de Camargo; Paulo Cesar Koch Nogueira
Journal:  Pediatr Nephrol       Date:  2021-03-06       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.